|
|
|
Volumn 47, Issue 4, 2011, Pages 154-158
|
|
[Molecular predictive markers of EGFR-targeted therapy in metastatic colorectal cancer].;Molekulární prediktory cílené anti-EGFR terapie u metastatického kolorektálního karcinomu.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
B RAF KINASE;
BRAF PROTEIN, HUMAN;
CETUXIMAB;
EPIDERMAL GROWTH FACTOR RECEPTOR;
KRAS PROTEIN, HUMAN;
MONOCLONAL ANTIBODY;
ONCOPROTEIN;
PANITUMUMAB;
PHOSPHATIDYLINOSITOL 3 KINASE;
PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE;
PIK3CA PROTEIN, HUMAN;
RAS PROTEIN;
CARCINOMA;
COLORECTAL TUMOR;
DRUG ANTAGONISM;
GENETICS;
HUMAN;
METASTASIS;
MOLECULARLY TARGETED THERAPY;
MUTATION;
PATHOLOGY;
PROGNOSIS;
REVIEW;
ANTIBODIES, MONOCLONAL;
ANTINEOPLASTIC AGENTS;
CARCINOMA;
COLORECTAL NEOPLASMS;
HUMANS;
MOLECULAR TARGETED THERAPY;
MUTATION;
PHOSPHATIDYLINOSITOL 3-KINASES;
PROGNOSIS;
PROTO-ONCOGENE PROTEINS;
PROTO-ONCOGENE PROTEINS B-RAF;
PTEN PHOSPHOHYDROLASE;
RAS PROTEINS;
RECEPTOR, EPIDERMAL GROWTH FACTOR;
|
|
EID: 84855740352
PISSN: 12107875
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (3)
|
|
References (0)
|
